BRCA2 and ovarian cancer: Prior studies have elucidated key genes in the homologous recombination pathway, including BRCA1, BRCA2, RAD51, and PALB2, that commonly have pathogenic germline variants and/or somatic mutations in breast and ovarian cancers (1).